Form 8-K - Current report:
SEC Accession No. 0001641172-25-002119
Filing Date
2025-04-01
Accepted
2025-04-01 17:03:34
Documents
14
Period of Report
2025-03-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43225
  Complete submission text file 0001641172-25-002119.txt   219462

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sonn-20250331.xsd EX-101.SCH 3017
3 XBRL LABEL FILE sonn-20250331_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE sonn-20250331_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3700
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 25800688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)